Telix Pharmaceuticals Ltd insider trading

Every open-market purchase and sale by Telix Pharmaceuticals Ltd's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.

Insider purchases, 5 years $1M 3 trades by 2 insiders Insider sales, 5 years $0 0 trades by 0 insiders

Insider purchase Insider sale Marker size reflects trade value. Weekly closes adjusted for splits; may be delayed.

Telix Pharmaceuticals Ltd insider open-market trades
Date	Insider	Trade	Shares	Price	Value	1M after	3M after	6M after

From insiders' Form 4 filings with the SEC: open-market purchases and sales only (awards, option exercises and shares withheld for tax are excluded), combined to one line per insider per day. "Plan" marks trades the filing says were made under a pre-set Rule 10b5-1 trading plan, which are scheduled in advance. Price changes run from the close on the trade date; hover a figure for the change relative to the S&P 500. Past moves don't predict future ones.

Does following Telix Pharmaceuticals Ltd’s insiders pay?

From May 6, 2026 to September 14, 2026, 2 insiders reported 2 open-market purchases and 0 sales not made under a pre-set plan in Telix Pharmaceuticals Ltd. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on May 7, 2026 into $8,532 by November 2, 2026, −27.8% a year. It held shares 100% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $10,393 (+8.2% a year), and held throughout $10,393 (+8.2%).

Copying Telix Pharmaceuticals Ltd's insidersS&P 500, same days investedS&P 500, held throughout $10,000 copying every open-market purchase by Telix Pharmaceuticals Ltd's insiders from May 7, 2026, before costs and taxes, marked weekly. Uninvested money earns the Treasury bill rate; the portfolio held shares 100% of the time.

Telix Pharmaceuticals Ltd: each insider's record
Insider	Role	Purchases	12 months after their purchases	Beat the S&P 500	Sales	12 months after their sales	Latest report
Behrenbruch Christian	MD & Group CEO	1	—	—	0	—	May 6, 2026
Smith Darren Charlton	Group Chief Financial Officer	1	—	—	0	—	September 14, 2026

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.

← Back to Telix Pharmaceuticals Ltd · Funds · Politicians